Company Announcements

Directorate Change

Source: RNS
RNS Number : 2647E
NatWest Group plc
21 October 2025
 

NatWest Group plc

Directorate Changes

 

NatWest Group plc ('NWG') announces the appointment of Josh Critchley as an independent non-executive director with effect from 3 November 2025.

 

Rick Haythornthwaite, Chair of NWG, said:

 

"I am delighted to welcome Josh to the NWG Board. Josh brings over three decades of experience in investment banking and capital markets, having advised boards and management teams across a wide range of industries and geographies. His deep expertise in financial services and strategic advisory will be a valuable asset to the Board."

 

Josh is a former Vice Chair of Global Investment Banking at the Royal Bank of Canada, and prior to joining RBC in 2009, held senior roles at Goldman Sachs and Merrill Lynch.

 

Josh currently serves as Trustee and Investment Committee Chair at Great Ormond Street Hospital Children's Charity and is an Honorary Senior Visiting Fellow at Bayes Business School, City St. George's, University of London.

 

There are no further matters requiring disclosure under Listing Rule 6.4.8R.

 

For further information contact:

NatWest Group Investor Relations:

Claire Kane

Director of Investor Relations

+44 (0) 20 7672 1758

 

NatWest Group Media Relations:

+44 (0) 131 523 4205

 

LEI: 2138005O9XJIJN4JPN90

-------------------------------------------------

 

Josh Critchley Biography

 

Josh Critchley is a former Vice Chair of Global Investment Banking for the Royal Bank of Canada. He was previously their long-time Head of European and Asian Investment Banking, serving in that role for twelve years (2011 - 2022), including seven years as a member of RBC Capital Markets' Global Operating Committee.

 

He joined RBC in 2009 to help lead the build-out of RBC's investment banking and equities footprint in Europe as part of RBC becoming a full-service investment banking provider.  Before Royal Bank of Canada, Josh held senior roles at Goldman Sachs and Merrill Lynch.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAZFLFLEBLXFBD